Analyst Ratings for Dianthus Therapeutics (DNTH)
DNTH Rating Summary
DNTH Price Target Summary
- Highest: $200.00 (Guggenheim)
- Lowest: $44.00 (Wedbush)
- Average: $84.80
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$84.80 (+30.1%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$84.80 (+30.1%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/14/2025 | Truist Securities | Danielle Brill | New Coverage | Buy (N/A) |
56.00 (N/A) |
34.42 (65.20) |
89.42% | Details |
| 9/17/2025 | Clear Street | Bill Maughan | New Coverage | Buy (N/A) |
100.00 (N/A) |
37.04 (65.20) |
76.03% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
